文献速递皮肤肿瘤

头颈部黑色素瘤Mohs显微描记手术与广泛局部切除的总生存比较

Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision.
PubMed 文献 · J Am Acad Dermatol · 2019-08-29

基于美国国家癌症数据库2004-2015年头颈部黑色素瘤数据,共纳入50,397例,其中3510例(7%)接受Mohs显微描记手术(MMS),46,887例(93%)接受广泛局部切除(WLE)。控制潜在混杂因素后,MMS组5年生存优于WLE组(HR 1.181,95%CI 1.083-1.288;P<.001)。结论认为MMS是头颈部黑色素瘤的有效治疗选择,数据库数据提示MMS可能带来生存获益。

要点

  • 头颈部黑色素瘤中MMS组5年生存优于WLE组(HR 1.181,95%CI 1.083-1.288;P<.001)。
  • 男性、肿瘤溃疡、手术切缘阳性与生存劣势显著相关。
  • 患者生存与肿瘤Breslow深度呈反比。

核心结论

  • MMS是头颈部黑色素瘤的有效治疗选择,国家癌症数据库数据提示MMS可能较WLE带来生存获益。

研究设计与样本

  • 基于美国国家癌症数据库2004-2015年头颈部黑色素瘤数据的回顾性分析,共50,397例,MMS组3510例(7%),WLE组46,887例(93%)。

主要发现

  • 控制潜在混杂变量后,MMS组较WLE组5年生存更优(HR 1.181,95%CI 1.083-1.288;P<.001)。
  • 男性(HR 1.287,95%CI 1.242-1.357;P=0)、肿瘤溃疡(HR 1.687,95%CI 1.616-1.760;P=0)、手术切缘阳性(HR 1.395,95%CI 1.306-1.490;P=0)与生存劣势显著相关。
  • 患者生存与肿瘤Breslow深度呈反比。

临床怎么用

  • 在头颈部黑色素瘤手术决策中,可将MMS作为WLE之外的有效选择,尤其需关注切缘状态、溃疡及Breslow深度等预后因素。

局限性

  • 为数据库研究,且MMS治疗的黑色素瘤数量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal surgical management for melanoma of the head and neck remains controversial. OBJECTIVE: Assess outcomes for melanomas of the head and neck treated with Mohs micrographic surgery (MMS) versus wide local excision (WLE) from the National Cancer Database. METHODS: Head and neck melanoma data from the National Cancer Database from years 2004-2015 were analyzed. RESULTS: In total, 50,397 cases of head and neck melanoma were reviewed; 3510 (7%) were treated with MMS and 46,887 (93%) with WLE. After controlling for potential confounding variables, patients treated with MMS were more likely than patients treated with WLE to survive after 5 years (hazard ratio [HR] 1.181, 95% confidence interval [CI] 1.083-1.288; P < .001). Factors associated with a statistically significant survival disadvantage included male sex (HR 1.287, 95% CI 1.242-1.357; P = 0), tumor ulceration (HR 1.687, 95% CI 1.616-1.760; P = 0), and positive surgical margins (HR 1.395, 95% CI 1.306-1.490; P = 0). Patient survival was inversely proportional to tumor Breslow depth. LIMITATIONS: Database study, limited number of MMS treated melanomas. CONCLUSION: MMS is a valid treatment option for melanoma of the head and neck; National Cancer Database data suggests that MMS might confer a survival benefit over WLE.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Hanson J, Demer A, Liszewski W, et al. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision. J Am Acad Dermatol. 2019. PMID: 31473297. doi:10.1016/j.jaad.2019.08.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。